BTK-IN-23

CAS No. 1227206-13-4

BTK-IN-23( —— )

Catalog No. M10877 CAS No. 1227206-13-4

BTK-IN-23 is a highly potent and selective Btk inhibitor with IC50 of 3 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BTK-IN-23
  • Note
    Research use only, not for human use.
  • Brief Description
    BTK-IN-23 is a highly potent and selective Btk inhibitor with IC50 of 3 nM.
  • Description
    BTK-IN-23 is a highly potent and selective Btk inhibitor with IC50 of 3 nM; displays 5-fold and 77-fold selectivity over BMX and TEC, >300-fold selectivity over FGR, SRC and MELK; demonstrates potent inhibition of anti-IgE stimulated CD63 expression on basophils, with an EC50 of 257 nM; shows improved stability compared to GDC-0834.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    BTK
  • Recptor
    BTK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1227206-13-4
  • Formula Weight
    529.594
  • Molecular Formula
    C27H24FN7O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    N-(6-fluoro-2-methyl-3-(5-((5-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl)amino)-6-oxo-1,6-dihydropyridazin-3-yl)phenyl)benzo[b]thiophene-2-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Young WB, et al. Bioorg Med Chem Lett. 2016 Jan 15;26(2):575-9.
molnova catalog
related products
  • BTK IN-1

    BTK IN-1 (SNS062 analog) is an effective BTK inhibitor (IC50: <100 nM).

  • Fenebrutinib

    An orally bioavailable, selective, non-covalent and reversible BTK inhibitor with IC50 of 2-9 nM.

  • CGI-1746

    CGI-1746 is a potent, highly selective, second-generation BTK inhibitor with IC50 of 1.9 nM.